Exploration of the pathogenic mechanisms of inherited cardiomyopathies caused by cardiac troponin T mutations

心肌肌钙蛋白T突变所致遗传性心肌病发病机制探讨

基本信息

  • 批准号:
    15300136
  • 负责人:
  • 金额:
    $ 9.41万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

Dilated cardiomyopathy (DCM) represents a heterogeneous group of inherited and acquired disorders characterized by cardiac dilation and systolic dysfunction, which leads to heart failure and sudden death, being the primary indication for cardiac transplantation. DCM-causing mutations have been found in the genes for cytoskeletal and sarcomeric proteins. We have created a knock-in mouse model for DCM caused by the deletion mutation ΔK210 in cardiac troponin T. Mutant mice developed enlarged hearts and showed a high incidence of sudden death with no sign of heart failure. Histological examination of cardiac sections from mutant mice showed a significant dilation of both ventricles with mild to moderate fibrosis. Echocardiography measurements showed that the ejection fraction of left ventricle was significantly smaller in mutant mice than in wild-type mice, indicating a reduced systolic function of mutant mice hearts in vivo. Isolated working heart preparations from mutant mice showed a decreased dP/dt_<max> with no significant change in dP/dt_<min>. However, no significant reduction in cardiac output was found in mutant mice, suggesting a complete compensation by ventricular enlargement. Studies using a telemetry system for ECG recording strongly suggested that the deletion mutation ΔK210 in cardiac troponin T results in a high incidence of sudden death due to a cardiac electrophysiological abnormality despite well-compensated mechanical performance of the heart.
扩张型心肌病(Dilated cardiomyopathy,DCM)是一组以心脏扩张和收缩功能障碍为特征的遗传性和获得性疾病,其导致心力衰竭和猝死,是心脏移植的主要指征。已在细胞骨架蛋白和肌节蛋白的基因中发现了导致DCM的突变。我们已经建立了一个基因敲入小鼠模型,用于心肌肌钙蛋白T缺失突变ΔK210引起的DCM。突变小鼠的心脏增大,猝死的发生率很高,没有心力衰竭的迹象。突变小鼠心脏切片的组织学检查显示两个心室显著扩张,伴有轻度至中度纤维化。超声心动图测量显示,突变小鼠的左心室射血分数显著小于野生型小鼠,表明突变小鼠心脏在体内的收缩功能降低。从突变小鼠分离的工作心脏制备物显示dP/dt_降低<max>,而dP/dt_无显著变化<min>。然而,在突变小鼠中没有发现心输出量的显著减少,表明心室扩大的完全补偿。使用遥测系统进行ECG记录的研究强烈表明,尽管心脏具有良好的代偿性机械性能,但心肌肌钙蛋白T中的缺失突变ΔK210导致心脏电生理异常导致猝死的发生率很高。

项目成果

期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Troponin I inhibitory peptide suppresses the force generation in smooth muscle by directly interfering the cross-bridge formation.
肌钙蛋白 I 抑制肽通过直接干扰跨桥形成来抑制平滑肌中力的产生。
Several aspects of Ca-regulatory mechanisms linked to Troponin
与肌钙蛋白相关的 Ca 调节机制的几个方面
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ohno T;Sakurai M;I.Ohtsuki et al.
  • 通讯作者:
    I.Ohtsuki et al.
SCH00013, a novel Ca(2+) sensitizer with positive inotropic and no chronotropic action in heart failure.
SCH00013,一种新型 Ca(2) 敏化剂,对心力衰竭具有正性肌力作用,但无变时作用。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    N. Tadano;S. Morimoto;A. Yoshimura;M. Miura;K. Yoshioka;M. Sakato;I. Ohtsuki;Y. Miwa;F. Takahashi;T. Sasaguri
  • 通讯作者:
    T. Sasaguri
Qun-Wei Lu: "Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca^<2+>-desensitization"J.Mol.Cell.Cardiol.. 35(12). 1421-1427 (2003)
Qun-Wei Lu:“扩张型心肌病中发现的心肌肌钙蛋白T突变R141W稳定了肌钙蛋白T-原肌球蛋白相互作用并导致Ca^2-脱敏”J.Mol.Cell.Cardiol.. 35(12)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
モデル動物の作製と維持
模型动物的创建和维护
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    小澤哲夫;北島 勲
  • 通讯作者:
    北島 勲
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MORIMOTO Sachio其他文献

MORIMOTO Sachio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MORIMOTO Sachio', 18)}}的其他基金

Pathogenic mechanism of congestive heart failure in a mouse model of dilated cardiomyopathy with brain serotonin dysfunction
扩张型心肌病伴脑血清素功能障碍小鼠模型充血性心力衰竭的发病机制
  • 批准号:
    23300145
  • 财政年份:
    2011
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Exploration of the pathogenic mechanisms of inherited cardiomyopathies caused by cardiac troponin T mutations
心肌肌钙蛋白T突变所致遗传性心肌病发病机制探讨
  • 批准号:
    17300129
  • 财政年份:
    2005
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional analyset of mutations in human cardiac troponin T that cause familial hypertrophic cardiomyopathy
导致家族性肥厚型心肌病的人心肌肌钙蛋白T突变的功能分析
  • 批准号:
    11670045
  • 财政年份:
    1999
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanism of pH sensitivity of muscle contraction : investigation using site-directed mutagenesis
肌肉收缩 pH 敏感性的分子机制:利用定点突变进行研究
  • 批准号:
    08680891
  • 财政年份:
    1996
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Stratification, Management, and Guidance of Hypertrophic Cardiomyopathy Patients using Hybrid Digital Twin Solutions
使用混合数字孪生解决方案对肥厚型心肌病患者进行分层、管理和指导
  • 批准号:
    10109598
  • 财政年份:
    2024
  • 资助金额:
    $ 9.41万
  • 项目类别:
    EU-Funded
A study on the identification of target factors for elucidation of the pathogenesis of hypertrophic cardiomyopathy and development of novel treatments
阐明肥厚型心肌病发病机制和开发新疗法的靶标因素的研究
  • 批准号:
    22KJ1699
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing CRISPR-based therapies for hypertrophic cardiomyopathy using human cardiomyocytes in a dish
使用培养皿中的人类心肌细胞开发基于 CRISPR 的肥厚型心肌病疗法
  • 批准号:
    2884313
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Studentship
High-Intensity Ultrasound Ablation for Septal Reduction Therapy of Hypertrophic Cardiomyopathy
高强度超声消融室间隔缩小术治疗肥厚型心肌病
  • 批准号:
    10818081
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
Modeling myosin mechanobiology towards understanding the mechanisms of hypertrophic cardiomyopathy
模拟肌球蛋白力学生物学以了解肥厚型心肌病的机制
  • 批准号:
    10906499
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
A multi-modal approach for efficient, point-of-care screening of hypertrophic cardiomyopathy
一种高效、即时筛查肥厚型心肌病的多模式方法
  • 批准号:
    10749588
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy
微创高强度超声治疗梗阻性肥厚型心肌病
  • 批准号:
    10603460
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
Missense Variants in Myosin Binding Protein C that Cause Hypertrophic Cardiomyopathy
导致肥厚性心肌病的肌球蛋白结合蛋白 C 的错义变异
  • 批准号:
    10752380
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
Transcriptomics, pathobiology, and cardiac event in hypertrophic cardiomyopathy
肥厚型心肌病的转录组学、病理学和心脏事件
  • 批准号:
    10638722
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy
微创高强度超声治疗梗阻性肥厚型心肌病
  • 批准号:
    10851470
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了